WXXWY Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 15:59):

Stats
Today's Volume	62 262.00
Average Volume	293 493
Market Cap	6.88B
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	12.42
ATR14	$0.00800 (0.25%)

Volume Correlation

Long: 0.14 (neutral)

Short: -0.12 (neutral)

Signal:(58.176) Neutral

WuXi Biologics (Cayman) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

WuXi Biologics (Cayman) Correlation - Currency/Commodity

0.35
( neutral )

0.48
( neutral )

0.00
( neutral )

0.56
( weak )

-0.75
( moderate negative )

0.54
( weak )

WuXi Biologics (Cayman) Financials

Annual	2022
Revenue:	$15.27B
Gross Profit:	$6.72B (44.04 %)
EPS:	$1.060

Q2	2023
Revenue:	$8.49B
Gross Profit:	$3.56B (41.93 %)
EPS:	$0.520

Q4	2022
Revenue:	$8.06B
Gross Profit:	$3.31B (41.07 %)
EPS:	$0.430

Q2	2022
Revenue:	$7.21B
Gross Profit:	$3.41B (47.36 %)
EPS:	$0.580

Financial Reports:

No articles found.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.